AxoGen Announces Proposed Public Offering of Common Stock

AxoGen (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced today that it has commenced an underwritten public offering of 2,000,000 shares of its common stock. In addition, AxoGen expects to grant the underwriters a 30-day option to purchase up to an aggregate of an additional 300,000 shares of common stock sold in connection with the offering at the public offering price.

As quoted in the press release:

AxoGen intends to use the net proceeds from the proposed offering for long term facility and capacity expansion and general corporate purposes.

Jefferies LLC and Leerink Partners LLC are acting as joint book-running managers for the offering. William Blair & Company, L.L.C.  and JMP Securities LLC are acting as co-managers. The offering is subject to market conditions, there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Click here to read the full press release.